Lumos Diagnostics Holdings Ltd

LDX

Company Profile

  • Business description

    Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.

  • Contact

    2724 Loker Avenue West
    CarlsbadCA92010
    USA

    T: +1 855 586-6739

    https://www.lumosdiagnostics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

Stocks News & Analysis

stocks

Earnings margins to improve for mining specialist

Premium products drive margins yet shares fully valued.
stocks

3 ASX opportunities after earnings season

Uncovering key opportunities following results.
stocks

Nvidia: Hugging Face acquisition both a wise offensive and defensive move

We think this improves Nvidia’s position within the open-source community.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,204.208.50-0.09%
CAC 408,278.777.63-0.09%
DAX 4026,046.4043.080.17%
Dow JONES (US)53,414.25271.86-0.51%
FTSE 10010,831.090.43-0.00%
HKSE25,374.96275.91-1.08%
NASDAQ26,506.9977.07-0.29%
Nikkei 22566,058.651,037.711.60%
NZX 50 Index13,920.8153.37-0.38%
S&P 5007,718.6029.11-0.38%
S&P/ASX 2009,013.1010.30-0.11%
SSE Composite Index3,920.709.42-0.24%

Market Movers